Ahmad Sadr
Corporate Officer/Principal bij APELLIS PHARMACEUTICALS, INC.
Actieve functies van Ahmad Sadr
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
APELLIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Hoofd Techniek/Wetenschap/O&O | 01-01-2017 | - |
Loopbaan van Ahmad Sadr
Eerdere bekende functies van Ahmad Sadr
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-05-2016 | 01-01-2017 |
Vision Medicines, Inc.
Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Hoofd Techniek/Wetenschap/O&O | 01-04-2015 | 01-05-2016 |
Opleiding van Ahmad Sadr
Widener University | Graduate Degree |
University of Maryland | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
Operationeel
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Graduate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
APELLIS PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Vision Medicines, Inc.
Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Health Technology |
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- Ahmad Sadr
- Ervaring